Search Reset All Therapy AreasAge-Related Macular DegenerationBreast CancerCardiovascularColorectal CancerCrohn's DiseaseDiabetic Macular EdemaDiabetic RetinopathyInfectious DiseaseOncologyOphthalmologyRespiratoryRheumatoid ArthritisRheumatologyUlcerative Colitis All ProductsBiosimilarsChina In-DepthCurrent TreatmentEmerging TherapiesEpidemiologyProductSpecial Topics / OtherTreatment Algorithms: Claims Data AnalysisUnmet Need All GeographyAsia PacificBrazilChinaFranceGeographyGermanyMexicoUS All Years20242023202220212020201920182017201620152014 Previous1...891011Next January 22, 2016 Emerging Biosimilars | Immunology | Inflectra/Remsima Wave 2 | Germany | 2016 December 18, 2015 Biosimilars | Emerging Biosimilars | Oncology | Zarxio Wave 1 | US November 13, 2015 Biosimilars Advisory Service : Physician Perspectives on Granulocyte Colony-Stimulating Factors and Monoclonal Antibodies in Oncology | US | 2015 October 30, 2015 Biosimilars Advisory Service : Physician Perspectives on Erythropoiesis-Stimulating Agents, Insulin, and Human Growth Hormone | US/EU5/Japan | 2015 September 29, 2015 Biosimilars Advisory Service : Physician Perspectives on Biologics in Rheumatology and Gastroenterology | US/EU5/Japan | 2015 September 1, 2015 Emerging Biosimilars | Immunology | Inflectra/Remsima Wave 1 | Germany | 2015 August 12, 2015 Biosimilars Advisory Service : Acceptance of Biosimilars Across Physician Specialties | US,France and Germany | 2015 July 13, 2015 Biosimilars Advisory Service : US and EU Payer Perspectives on Biosimilars | US/EU | 2015 March 31, 2015 Biosimilars Advisory Service : Corporate Strategies | G7 | 2015 March 31, 2015 The Impact of Biosimilars in NHL, Breast Cancer, and Colorectal Cancer | Physician & Payer Forum | Brazil and Mexico | 2015 March 31, 2015 Biosimilars Advisory Service : Global Biosimilars Markets – Regulations, Pipelines, and Major Players | G7 | 2015 January 12, 2015 Biosimilars in 2014: Landmark Events and What They Mean for 2015 and Beyond January 2, 2015 EU5 Market Access Opportunities and Challenges for Current and Emerging Rheumatoid Arthritis Agents Amid the Launches of Oral Jak Inhibitors and Biosimilars | Physician & Payer Forum | EU5 | 2014 November 5, 2014 Granulocyte Colony-Stimulating Factors and Monoclonal Antibodies in Oncology (Physician Perspectives) | Biosimilars Advisory Service | US/Eu5/Japan | 2014 October 24, 2014 Erythropoiesis-Stimulating Agents, Insulin, and Human Growth Hormone (Physician Perspectives) | Biosimilars Advisory Service | US/EU5/Japan | 2014 Previous1...891011Next